Efficacy and tolerability balance of oxycodone/naloxone and tapentadol in chronic low back pain with a neuropathic component: a blinded end point analysis of randomly selected routine data from 12-week prospective open-label observations.
about
Response to the publication by Ueberall and Mueller-SchwefeRetrospective analyses versus RCTs: comparing like with like?Oxycodone/Naloxone Prolonged Release: A Review in Severe Chronic Pain.Oral prolonged-release oxycodone/naloxone for managing pain and opioid-induced constipation: A review of the evidence.Methodological Aspects in Studies Based on Clinical Routine Data.Spontaneously reported adverse drug events related to tapentadol and oxycodone/naloxone in Australia.
P2860
Efficacy and tolerability balance of oxycodone/naloxone and tapentadol in chronic low back pain with a neuropathic component: a blinded end point analysis of randomly selected routine data from 12-week prospective open-label observations.
description
2016 nî lūn-bûn
@nan
2016 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Efficacy and tolerability bala ...... ctive open-label observations.
@ast
Efficacy and tolerability bala ...... ctive open-label observations.
@en
type
label
Efficacy and tolerability bala ...... ctive open-label observations.
@ast
Efficacy and tolerability bala ...... ctive open-label observations.
@en
prefLabel
Efficacy and tolerability bala ...... ctive open-label observations.
@ast
Efficacy and tolerability bala ...... ctive open-label observations.
@en
P2860
P921
P356
P1476
Efficacy and tolerability bala ...... ctive open-label observations.
@en
P2093
Gerhard H H Mueller-Schwefe
Michael A Ueberall
P2860
P304
P356
10.2147/JPR.S112418
P577
2016-11-11T00:00:00Z